Most cited papers from Kurume University

Kurume University

What are the most cited papers from Kurume University?

The most cited paper from Kurume University is "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement" (Mohammed Eslam et al., 2020), with 4,540 citations. Next come "Ghrelin: Structure and Function" (2,808) and "Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer" (2,496).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 610 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Mohammed Eslam et al. · Journal of Hepatology Open access	8 Apr 2020	4,540
2	Ghrelin: Structure and Function Masayasu Kojima, Kenji Kangawa · Physiological Reviews Review	23 Mar 2005	2,808
3	Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer Japanese Society for Cancer of the Colon and Rectum et al. · International Journal of Clinical Oncology Open access	27 Mar 2017	2,496
4	International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study Franck Pagès et al. · The Lancet	May 2018	2,133
5	Indices of relative weight and obesity Ancel B. Keys, Flaminio Fidanza, Martti J. Karvonen et al. · Journal of Chronic Diseases	Jul 1972	2,085
6	THE DIET AND 15-YEAR DEATH RATE IN THE SEVEN COUNTRIES STUDY Ancel B. Keys, ALESSANDRO MIENOTTI, MARITI J. KARVONEN et al. · American Journal of Epidemiology	Dec 1986	1,804
7	Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara et al. · The Lancet	Aug 2002	1,747
8	Mitochondrial diseases Gráinne S. Gorman, Patrick Francis Chinnery, Salvatore DiMauro et al. · Nature Reviews Disease Primers Review	20 Oct 2016	1,621
9	Angiogenesis in cancer Naoyo Nishida, Hirohisa Yano, Takashi Nishida et al. · Vascular Health and Risk Management Open access	Aug 2006	1,449
10	A new protein containing an SH2 domain that inhibits JAK kinases Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi et al. · Nature	26 Jun 1997	1,420
11	Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours Jérôme Galon et al. · The Journal of Pathology Open access	11 Oct 2013	1,370
12	Long-term Consequences of Kawasaki Disease Hirohisa Kato, T. Sugimura, Teiji Akagi et al. · Circulation	15 Sep 1996	1,340
13	Current Understanding of Dysbiosis in Disease in Human and Animal Models Arianna K. DeGruttola, Daren Low, Atsushi Mizoguchi et al. · Inflammatory Bowel Diseases Open access	19 Apr 2016	1,146
14	Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors	8 Jul 2021	1,130
15	Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan Haruhiko Yoshida, Yasushi Shiratori, Mitsuhiko Moriyama et al. · Annals of Internal Medicine	3 Aug 1999	1,103
16	The power of genetic diversity in genome-wide association studies of lipids Sarah E. Graham et al. · Nature Open access527 authors	9 Dec 2021	1,099
17	Explanation of machine learning models using shapley additive explanation and application for real data in hospital Yasunobu Nohara, Koutarou Matsumoto, Hidehisa Soejima et al. · Computer Methods and Programs in Biomedicine Open access	10 Dec 2021	1,073
18	Ghrelin Timo D. Müller et al. · Molecular Metabolism Open access	7 Apr 2015	1,036
19	Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region Fumihiko Ishikawa, Shuro Yoshida, Yoriko Saito et al. · Nature Biotechnology	21 Oct 2007	1,000
20	Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines Hiroshi Kamihata, Hiroaki Matsubara, Takashi Nishiue et al. · Circulation	28 Aug 2001	975
21	Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) Ichizo Nishino, Jin Fu, Kurenai Tanji et al. · Nature	Aug 2000	955
22	A saturated map of common genetic variants associated with human height Loïc Yengo et al. · Nature Open access632 authors	12 Oct 2022	934
23	Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial Toyoaki Hida et al. · The Lancet	11 May 2017	927
24	The trans-ancestral genomic architecture of glycemic traits Jihua Chen et al. · Nature Genetics Open access417 authors	31 May 2021	918
25	Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization Toyoaki Murohara, Hisao Ikeda, Junli Duan et al. · Journal of Clinical Investigation Open access	Jun 2000	899
26	The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease Mohammed Eslam et al. · Hepatology International Open access	Oct 2020	863
27	Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # † International Consensus Group for Hepatocellular Neoplasia · Hepatology Open access	24 Oct 2008	845
28	Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version Masatoshi Kudo, Namiki Izumi, Norihiro Kokudo et al. · Digestive Diseases	2011	831
29	Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients Kenichi Takayasu, Shigeki Arii, Iwao Ikai et al. · Gastroenterology Open access	Aug 2006	813
30	Clinical characteristics of clear cell carcinoma of the ovary Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa et al. · Cancer	Jun 2000	810
31	Cancer classification using the Immunoscore: a worldwide task force Jérôme Galon et al. · Journal of Translational Medicine Open access	3 Oct 2012	807
32	Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009 Vinzenz Oji et al. · Journal of the American Academy of Dermatology	21 Jul 2010	805
33	The First International Consensus on Mucous Membrane Pemphigoid Lawrence S. Chan et al. · Archives of Dermatology	Mar 2002	794
34	Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation Anubha Mahajan et al. · Nature Genetics Open access354 authors	May 2022	774
35	Advancing the global public health agenda for NAFLD: a consensus statement Jeffrey Victor Lazarus et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access221 authors	27 Oct 2021	768
36	Endogenous Nitric Oxide Synthase Inhibitor Hiroshi Miyazaki, Hidehiro Matsuoka, John P. Cooke et al. · Circulation Open access	9 Mar 1999	765
37	Rising incidence of early-onset colorectal cancer — a call to action Naohiko Akimoto, Tomotaka Ugai, Rong Zhong et al. · Nature Reviews Clinical Oncology ReviewOpen access	20 Nov 2020	739
38	Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial Masatoshi Kudo et al. · Gut Open access	4 Dec 2019	739
39	Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers Tania Roskams et al. · Hepatology Open access	30 Apr 2004	736
40	DARPP-32: An Integrator of Neurotransmission Per Svenningsson, Akinori Nishi, Gilberto Fisone et al. · The Annual Review of Pharmacology and Toxicology Review	27 Jan 2004	728
41	The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop Hideo Yasukawa, Hiroyuki Misawa, Hiroshi Sakamoto et al. · The EMBO Journal Open access	Mar 1999	726
42	Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Hideto Yonekura, Yasuhiko Yamamoto, Shigeru Sakurai et al. · Biochemical Journal Open access	12 Mar 2003	716
43	Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer Japanese Society for Cancer of the Colon and Rectum et al. · International Journal of Clinical Oncology	14 Oct 2011	715
44	Genetic Variation in the Gene Encoding Adiponectin Is Associated With an Increased Risk of Type 2 Diabetes in the Japanese Population Kazuo Hara et al. · Diabetes	Feb 2002	706
45	Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial Hiroyuki Hanai, Takayuki Iida, Ken Takeuchi et al. · Clinical Gastroenterology and Hepatology	14 Nov 2006	703
46	Requirement of CD9 on the Egg Plasma Membrane for Fertilization Kenji Miyado, Gen Yamada, Shuichi Yamada et al. · Science	14 Jan 2000	693
47	Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update Masatoshi Kudo et al. · Liver Cancer Open access	2021	689
48	Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer Koichi Azuma, Keiichi Ota, Akihiko Kawahara et al. · Annals of Oncology Open access	9 Jul 2014	685
49	Clinical features of isolated noncompaction of the ventricular myocardium Fukiko Ichida, Yuji Hamamichi, Toshio Miyawaki et al. · Journal of the American College of Cardiology Open access	Jul 1999	676
50	Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity Hiroyuki Mori, Reiko Hanada, Toshikatsu Hanada et al. · Nature Medicine	20 Jun 2004	657

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.